Malignant insulinoma: Recommendations for characterisation and treatment

被引:46
作者
Baudin, Eric [1 ]
Caron, Philippe [2 ]
Lombard-Bohas, Catherine [3 ]
Tabarin, Antoine [4 ]
Mitry, Emmanuel [5 ]
Reznick, Yves [6 ]
Taieb, David [7 ]
Pattou, Francois [8 ]
Goudet, Pierre [9 ]
Vezzosi, Delphine [2 ]
Scoazec, Jean-Yves [10 ]
Cadiot, Guillaume [11 ]
Borson-Chazot, Francoise [12 ]
Do Cao, Christine [13 ]
机构
[1] Inst Gustave Roussy, Serv Med Nucl & Oncol Endocrinienne, F-94800 Villejuif, France
[2] CHU Rangueil Larrey, Serv Endocrinol & Malad Metab, F-31400 Toulouse, France
[3] Hop Edouard Herriot, F-69003 Lyon, France
[4] Hop Haut Leveque, Serv Endocrinol, F-33604 Pessac, France
[5] Hop Ambroise Pare, Serv Hepatogastroenterol & Oncol Digest, F-92100 Boulogne, France
[6] CHU Cote Nacre, Unite Fonct Endocrinol & Malad Metab, F-14033 Caen, France
[7] CHU Timone, Serv Cent Biophys & Med Nucl, F-13385 Marseille, France
[8] Hop Claude Huriez, Serv Chirurg Endocrinienne, F-59037 Lille, France
[9] CHU Dijon, Serv Chirurg Gen & Endocrinienne, F-21079 Dijon, France
[10] Inst Gustave Roussy, Serv Biol & Pathol Med, F-94800 Villejuif, France
[11] Hop Robert Debre, Serv Hepatogastroenterol & Cancerol Digest, F-51090 Reims, France
[12] Hosp Civils Lyon, Ctr Med Nucl, F-69229 Lyon, France
[13] Hop Claude Huriez, Serv Endocrinol & Malad Metab, F-59037 Lille, France
关键词
NEUROENDOCRINE GASTROENTEROPANCREATIC TUMORS; RECEPTOR-MEDIATED RADIOTHERAPY; LONG-TERM SURVIVAL; PHASE-II TRIAL; SOMATOSTATIN ANALOG; LIVER METASTASES; PROGNOSTIC-FACTORS; ENDOCRINE TUMORS; SEVERE HYPOGLYCEMIA; MEDICAL-TREATMENT;
D O I
10.1016/j.ando.2013.07.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:523 / 533
页数:11
相关论文
共 129 条
[91]   Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma [J].
Panzuto, F ;
Di Fonzo, M ;
Iannicelli, E ;
Sciuto, R ;
Maini, CL ;
Capurso, G ;
Milione, M ;
Cattaruzza, MS ;
Falconi, M ;
David, V ;
Ziparo, V ;
Pederzoli, P ;
Bordi, C ;
Delle Fave, G .
ANNALS OF ONCOLOGY, 2006, 17 (03) :461-466
[92]   Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression [J].
Panzuto, Francesco ;
Boninsegna, Letizia ;
Fazio, Nicola ;
Campana, Davide ;
Brizzi, Maria Pia ;
Capurso, Gabriele ;
Scarpa, Aldo ;
De Braud, Filippo ;
Dogliotti, Luigi ;
Tomassetti, Paola ;
Delle Fave, Gianfranco ;
Falconi, Massimo .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) :2372-2377
[93]   Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype - Molecular analysis of a malignant insulinoma in a NF-1 patient [J].
Perren, Aurel ;
Wiesli, Peter ;
Schmid, Sonja ;
Montani, Matteo ;
Schmitt, Anja ;
Schmid, Christoph ;
Moch, Holger ;
Komminoth, Paul .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (08) :1047-1051
[94]  
Phan AT, 2010, ASCO M 2010 JUN 14 S, V28, P4001
[95]   Secular Trends in the Presentation and Management of Functioning Insulinoma at the Mayo Clinic, 1987-2007 [J].
Placzkowski, Kimberly A. ;
Vella, Adrian ;
Thompson, Geoffrey B. ;
Grant, Clive S. ;
Reading, Carl C. ;
Charboneau, J. William ;
Andrews, James C. ;
Lloyd, Ricardo V. ;
Service, F. John .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (04) :1069-1073
[96]   Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282 [J].
Ramanathan, RK ;
Cnaan, A ;
Hahn, RG ;
Carbone, PP ;
Haller, DG .
ANNALS OF ONCOLOGY, 2001, 12 (08) :1139-1143
[97]   Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors. [J].
Raymond, Eric ;
Dahan, Laetitia ;
Raoul, Jean-Luc ;
Bang, Yung-Jue ;
Borbath, Ivan ;
Lombard-Bohas, Catherine ;
Valle, Juan ;
Metrakos, Peter ;
Smith, Denis ;
Vinik, Aaron ;
Chen, Jen-Shi ;
Hoersch, Dieter ;
Hammel, Pascal ;
Wiedenmann, Bertram ;
Van Cutsem, Eric ;
Patyna, Shem ;
Lu, Dongrui Ray ;
Blanckmeister, Carolyn ;
Chao, Richard ;
Ruszniewski, Philippe .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06) :501-513
[98]  
Roche A, 2004, HEPATO-GASTROENTEROL, V51, P1751
[99]   Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2 [J].
Romeo, S ;
Milione, M ;
Gatti, A ;
Fallarino, M ;
Corleto, V ;
Morano, S ;
Baroni, MG .
HORMONE RESEARCH, 2006, 65 (03) :120-125
[100]   Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRα, PDGFRβ, and met in large-cell neuroendocrine carcinoma of the lung [J].
Rossi, G ;
Cavazza, A ;
Marchioni, A ;
Longo, L ;
Migaldi, M ;
Sartori, G ;
Bigiani, N ;
Schirosi, L ;
Casali, C ;
Morandi, U ;
Facciolongo, N ;
Maiorana, A ;
Bavieri, M ;
Fabbri, LM ;
Brambilla, E .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8774-8785